Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
57
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study

Yang Lyu1 Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer
,
Yang Yang2 Department of Anesthesia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer
,
Xin Li3 Department of Intensive Care Unit, Tianjin Medical University General Hospital, Tianjin
,
Min Peng3 Department of Intensive Care Unit, Tianjin Medical University General Hospital, Tianjin
,
Xin He2 Department of Anesthesia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer
,
Peng Zhang4 Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China
,
Shangwen Dong4 Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China
,
Wanhua Wang2 Department of Anesthesia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer
&
Donghao Wang1 Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for CancerCorrespondence[email protected]
 show all
Pages 31-37 | Published online: 21 Dec 2017

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ling-ling Zhu & Quan Zhou. (2018) Optimal infusion rate in antimicrobial therapy: explosion of evidence in the last five years. Infection and Drug Resistance 11, pages 1105-1117.
Read now

Articles from other publishers (4)

Pınar Kıran, Yasemin Nadir & Serap Gencer. (2023) Clinical efficacy and safety of prolonged versus intermittent administration of antipseudomonal beta-lactam antibiotics in adults with severe acute infections: A meta-analysis of randomized controlled trials. Journal of Infection and Chemotherapy.
Crossref
Sofie A. M. Dhaese, Eric A. Hoste & Jan J. De Waele. (2022) Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’. Antibiotics 11:7, pages 889.
Crossref
Mohd H. Abdul-Aziz, Federica Portunato & Jason A. Roberts. (2020) Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base. Current Opinion in Infectious Diseases 33:6, pages 501-510.
Crossref
Laila Aboulatta, Hideki Sugita, Hitomi Wakabayashi, Hisashi Noma & Tadanori Sasaki. (2020) Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: A systematic review and meta-analysis. International Journal of Infectious Diseases 98, pages 41-50.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.